Explore News
-
GLP-1s for $50 a Month? 14 Million Medicare Recipients May Be Eligible
Medicare pilot program reduces cost of GLP-1 medications for eligible recipients
-
Why Skin Substitutes Are at Center of Medicare Fraud
Medicare fraud charges target pricey skin substitutes
-
Why Novo and Lilly are Racing for GLP-1 Supremacy
Novo Nordisk and Eli Lilly rivalry intensifies in GLP-1 pill market
-
Medicare Bets $15B on Lower Drug Prices by 2027
A new ‘most favored nation’ pricing policy aims to slash costs for blockbuster weight-loss and…
-
Medicare Warns of Risks as CBD Trial Begins
A groundbreaking Medicare pilot program will test whether CBD can safely reduce chronic pain and…
-
Medicare to Cover GLP-1s for Weight Loss in 2024 Pilot
A new federal pilot program will test Medicare coverage of GLP-1 drugs like semaglutide and…
-
Why California Lost $1.3 Billion in Medicaid Funds
California’s Medicaid payments suspended due to alleged lack of fraud prosecution
-
Why Home Health Providers Face a Medicare Access Crisis
The Trump-Vance-Oz administration has halted new enrollments in Medicare for home health and hospice providers,…
-
Trump Weighs Major Gift to For-Profit Insurance Industry: Medicare Privatization
A potential overhaul of the Medicare system could have far-reaching consequences
